PHIBRO ANIMAL HEALTH CORP (PAHC)
Pharmaceutical Preparations · Healthcare · $2.2B
Intrinsic Value (Consensus)
$26.45
Current Price
$31.87
Margin of Safety
-17%
17% Above Intrinsic Value
Value: $26
Price: $32
Valuation Model Estimates
Current Price: $31.87
DCF (Discounted Cash Flow)
$46.35
Graham Number
$10.54
Earnings Power Value
$11.55
Relative Value (P/E)
$23.80
Dividend Discount Model
$40.00
Consensus Value
$26.45
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
68
Profitability
22/25
Strength
15/25
Valuation
9/25
Growth
22/25
Financial Health Signals
Elevated debt — Debt/Equity ratio is 109%
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $1.19
- EPS (Forward)
- $1.43
- Book Value
- $4.15
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 16.9%
- Debt/Equity
- 109%
- Revenue Growth
- 27.4%
- Earnings Growth
- 20.0%
- Dividend Yield
- 0.5%
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance